Buchumschlag

Extracellular vesicles as the next‐generation modulators of pharmacokinetics and pharmacodynamics of medications and their potential as adjuvant therapeutics

Fuente: Wiley Open Access

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	Jiaqi Liu, Joel Z. Nordin, Andrew J. McLachlan, Wojciech Chrzanowski
Format:	Artículo Open Access
Veröffentlicht:	Wiley 2024
Schlagworte:	Clinical and Translational Medicine
Online-Zugang:	Acceder al recurso
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge

Leveraging extracellular vesicle biology for novel tests and therapeutics for kidney fibrosis
von: Chin‐Ya Sophie Chiang, et al.
Veröffentlicht: (2026)

Mitochondria‐derived vesicles: A promising and potential target for tumour therapy
von: Xueqiang Peng, et al.
Veröffentlicht: (2025)

Angiotensin‐converting enzyme 2 modulation of pyroptosis pathway in traumatic brain injury: A potential therapeutic target
von: Jinxiu Guo, et al.
Veröffentlicht: (2024)

Stereo cell: A new approach to the next generation of clinical precision medicine
von: Wanxin Duan, et al.
Veröffentlicht: (2025)

Extracellular vesicles derived from creeping fat stem cells promote lymphatic function and restrain inflammation of Crohn's disease
von: Weigang Shu, et al.
Veröffentlicht: (2024)

Lactylation in cancer: Mechanisms in tumour biology and therapeutic potentials
von: Yipeng He, et al.
Veröffentlicht: (2024)

Unlocking beta cell health: The clinical potential of extracellular vesicles in type 1 diabetes
von: Nanthini Jayabalan, et al.
Veröffentlicht: (2026)

RNA methylation‐related inhibitors: Biological basis and therapeutic potential for cancer therapy
von: Huanxiang Chen, et al.
Veröffentlicht: (2024)

B‐cell performance in chemotherapy: Unravelling the mystery of B‐cell therapeutic potential
von: Zizhuo Li, et al.
Veröffentlicht: (2024)

Therapeutic potential of mesenchymal stem cell‐derived extracellular vesicles: A focus on inflammatory bowel disease
von: Laura Clua‐Ferré, et al.
Veröffentlicht: (2024)

Extracellular vesicle proteomics uncovers energy metabolism, complement system, and endoplasmic reticulum stress response dysregulation postexercise in males with myalgic encephalomyelitis/chronic fatigue syndrome
von: Katherine A. Glass, et al.
Veröffentlicht: (2025)

AdjuvareDB: A comprehensive database for candidate adjuvant compendium in clinic
von: Dekang Ren, et al.
Veröffentlicht: (2024)

Diagnostic and therapeutic potential of tonic gamma‐aminobutyric acid from reactive astrocytes in brain diseases
von: Wuhyun Koh, et al.
Veröffentlicht: (2024)

Immunostimulatory effects of Toll‐like receptor ligands as adjuvants in establishing a novel mouse model for pemphigus vulgaris
von: Changxing Gao, et al.
Veröffentlicht: (2024)

Translational inhalable extracellular vesicle‐based mRNA therapy for the treatment of lung cancer
von: Mengrui Liu, et al.
Veröffentlicht: (2025)

Soluble IL‐2R: A potential therapeutic target for mitochondrial dysfunction in post‐COVID fatigue syndrome
von: Laura P. Brown, et al.
Veröffentlicht: (2025)

Bispecific antibody targeting CD40 and HER2 potentiates therapeutic efficacy by reprogramming macrophages within the tumour microenvironment
von: Na Li, et al.
Veröffentlicht: (2025)

Huntington disease alters the actionable information in plasma extracellular vesicles
von: Andreas Neueder, et al.
Veröffentlicht: (2024)

Comprehensive pan‐cancer analysis of mitochondrial outer membrane permeabilisation activity reveals positive immunomodulation and assists in identifying potential therapeutic targets for immunotherapy resistance
von: Qingshan Chen, et al.
Veröffentlicht: (2024)

Bidirectional crosstalk between cancer cells and cancer‐associated fibroblasts in mixed organoid system elicits transcriptomic characteristics of pancreatic cancer with potential therapeutic vulnerabilities
von: Jae‐Il Choi, et al.
Veröffentlicht: (2024)

Pan‐cancer analyses of bromodomain containing 9 as a novel therapeutic target reveals its diagnostic, prognostic potential and biological mechanism in human tumours
von: Yu Chen, et al.
Veröffentlicht: (2024)

Novel insights into extracellular vesicles: An update on biomolecules, immunomodulation and clinical strategies in skin melanoma
von: Junshu Li, et al.
Veröffentlicht: (2026)

Adipose tissue‐derived extracellular vesicles aggravate temporomandibular joint osteoarthritis associated with obesity
von: Baochao Li, et al.
Veröffentlicht: (2024)

Liver regeneration after injury: Mechanisms, cellular interactions and therapeutic innovations
von: Qi Liu, et al.
Veröffentlicht: (2024)

Translational pharmacokinetic/pharmacodynamic model for mRNA‐0184, an investigational therapeutic for the treatment of heart failure
von: Neeraj Kaushal, et al.
Veröffentlicht: (2024)

Synthetic lethality in cancer therapy: Mechanisms, models and clinical translation for overcoming therapeutic resistance
von: Junyan Li, et al.
Veröffentlicht: (2026)

Glutamate as a therapeutic strategy to promote liver regeneration
von: María del Mar Rigual, et al.
Veröffentlicht: (2025)

Sources of pharmacokinetic and pharmacodynamic variability and clinical pharmacology studies of antiseizure medications in the pediatric population
von: Patricia D. Maglalang, et al.
Veröffentlicht: (2024)

Targeting capacity, safety and efficacy of engineered extracellular vesicles delivered by transdermal microneedles to treat plasmacytoma in mice
von: Yulin Cao, et al.
Veröffentlicht: (2025)

Ineffective control of Epstein–Barr virus infection is seen in MS: What is next?
von: Paulus Rommer, et al.
Veröffentlicht: (2024)

MiR‐146a engineered extracellular vesicles derived from mesenchymal stromal cells more potently attenuate ischaemia–reperfusion injury in lung transplantation
von: Xiucheng Yang, et al.
Veröffentlicht: (2025)

Safety, pharmacokinetics and efficacy of selumetinib in Chinese adult and paediatric patients with neurofibromatosis type 1 and inoperable plexiform neurofibromas: The primary analysis of a phase 1 open‐label study
von: Zhichao Wang, et al.
Veröffentlicht: (2024)

SHP2 inhibition and adjuvant therapy synergistically target KIT‐mutant GISTs via ERK1/2‐regulated GSK3β/cyclin D1 pathway
von: Chunxiao He, et al.
Veröffentlicht: (2025)

CRISPRi screening identifies PIKfyve as a co‐therapeutic target for obinutuzumab
von: Yerim Kim, et al.
Veröffentlicht: (2025)

Oncogenic driver and therapeutic target: Prolactin signalling axis in retroperitoneal sarcoma
von: Fu'an Xie, et al.
Veröffentlicht: (2026)

Tumour‐associated macrophage‐derived DOCK7‐enriched extracellular vesicles drive tumour metastasis in colorectal cancer via the RAC1/ABCA1 axis
von: Weiwei Chen, et al.
Veröffentlicht: (2024)

Engineered small extracellular vesicles for targeted delivery of perlecan to stabilise the blood–spinal cord barrier after spinal cord injury
von: Wei Peng, et al.
Veröffentlicht: (2025)

Depletion‐assisted multiplexed cell‐free RNA sequencing reveals distinct human and microbial signatures in plasma versus extracellular vesicles
von: Hongke Wang, et al.
Veröffentlicht: (2024)

Ninjurin1 in cardiovascular and vascular biology: From molecular mechanisms to therapeutic opportunities
von: Muhammad Mamunur Rashid Mahib
Veröffentlicht: (2026)

Ferroptosis in breast cancer: From adipocyte–immune–iron regulation to therapeutic application
von: Juan Sun, et al.
Veröffentlicht: (2026)